Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:28:43.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The header revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:37.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Related topic links for ovarian cancer and MedlinePlus Genetics were added to the page to improve cross-referencing for readers.
    Difference
    0.2%
    Check dated 2026-03-04T14:22:02.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Removes mentions of 'Ovarian cancer' and related topics such as 'MedlinePlus Genetics', reducing disease-specific context and linked informational resources on the study page.
    Difference
    0.2%
    Check dated 2026-02-25T09:27:36.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Added related topics to the page: 'Ovarian cancer' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T07:12:46.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    A minor site-wide revision marker (Revision: v3.4.2) was added, and a funding notice, a related topic (MedlinePlus Genetics), and an older revision reference (v3.4.1) were removed. These adjustments affect navigation and ancillary references but do not alter the study details for NCT02537444.
    Difference
    0.7%
    Check dated 2026-02-11T05:41:01.000Z thumbnail image

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.